OptiNose Valuation
| 0OP Stock | EUR 0.38 0.01 2.70% |
OptiNose seems to be fairly valued based on Macroaxis valuation methodology. Our model determines the value of OptiNose from analyzing the company fundamentals such as Shares Outstanding of 111.38 M, return on equity of -10.5, and Operating Margin of (0.76) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that OptiNose's price fluctuation is out of control at this time. Calculation of the real value of OptiNose is based on 3 months time horizon. Increasing OptiNose's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the OptiNose stock is determined by what a typical buyer is willing to pay for full or partial control of OptiNose. Since OptiNose is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OptiNose Stock. However, OptiNose's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.38 | Real 0.37 | Hype 0.38 |
The real value of OptiNose Stock, also known as its intrinsic value, is the underlying worth of OptiNose Company, which is reflected in its stock price. It is based on OptiNose's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of OptiNose's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of OptiNose helps investors to forecast how OptiNose stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OptiNose more accurately as focusing exclusively on OptiNose's fundamentals will not take into account other important factors: OptiNose Total Value Analysis
OptiNose is presently estimated to have takeover price of 257.48 M with market capitalization of 187.86 M, debt of 126.42 M, and cash on hands of 93.92 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the OptiNose fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
257.48 M | 187.86 M | 126.42 M | 93.92 M |
OptiNose Investor Information
About 78.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.86. OptiNose had not issued any dividends in recent years. The entity had 15:1 split on the 30th of September 2024. Based on the measurements of operating efficiency obtained from OptiNose's historical financial statements, OptiNose is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.OptiNose Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OptiNose has an asset utilization ratio of 44.95 percent. This implies that the Company is making €0.45 for each dollar of assets. An increasing asset utilization means that OptiNose is more efficient with each dollar of assets it utilizes for everyday operations.OptiNose Ownership Allocation
OptiNose owns a total of 111.38 Million outstanding shares. The majority of OptiNose outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in OptiNose to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in OptiNose. Please pay attention to any change in the institutional holdings of OptiNose as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.OptiNose Profitability Analysis
The company reported the revenue of 74.65 M. Net Loss for the year was (82.3 M) with profit before overhead, payroll, taxes, and interest of 65.5 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates OptiNose's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in OptiNose and how it compares across the competition.
About OptiNose Valuation
The stock valuation mechanism determines OptiNose's current worth on a weekly basis. Our valuation model uses a comparative analysis of OptiNose. We calculate exposure to OptiNose's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OptiNose's related companies.OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people.
8 Steps to conduct OptiNose's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates OptiNose's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct OptiNose's valuation analysis, follow these 8 steps:- Gather financial information: Obtain OptiNose's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine OptiNose's revenue streams: Identify OptiNose's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research OptiNose's industry and market trends, including the size of the market, growth rate, and competition.
- Establish OptiNose's growth potential: Evaluate OptiNose's management, business model, and growth potential.
- Determine OptiNose's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate OptiNose's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for OptiNose Stock analysis
When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |